eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

GlaxoSmithKline UK
Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 05/07/2010
PIL Seroxat 20mg/10ml oral suspension

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 05/07/2010 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 05/02/2010 and displayed until 05/07/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 12/05/2009 and displayed until 05/02/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to drug interactions
  • Change to information about pregnancy or lactation
Updated on 02/06/2008 and displayed until 12/05/2009
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change of inactive ingredient
  • Change to drug interactions
Updated on 10/08/2007 and displayed until 02/06/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 19/04/2007 and displayed until 10/08/2007
Reasons for adding or updating:
  • Change to date of revision
  • Change to information about pregnancy or lactation
  • Change to drug interactions
  • Change to side-effects
Updated on 01/03/2007 and displayed until 19/04/2007
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to drug interactions
  • Change to storage instructions
  • Change to date of revision
Updated on 10/03/2006 and displayed until 01/03/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 01/03/2006 and displayed until 10/03/2006
Reasons for adding or updating:
  • Change to date of revision
  • Change to information about pregnancy or lactation
  • Change to drug interactions
  • Change to side-effects
Updated on 20/01/2006 and displayed until 01/03/2006
Reasons for adding or updating:
  • Change to date of revision
  • Change to information about pregnancy or lactation
Updated on 18/02/2005 and displayed until 20/01/2006
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Improved Electronic Presentation
Updated on 18/06/2003 and displayed until 18/02/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 10/06/2003 and displayed until 18/06/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 10/05/2002 and displayed until 10/06/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 24/09/2001 and displayed until 10/05/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 03/08/2001 and displayed until 24/09/2001
Reasons for adding or updating:
  • Update to PIL
Updated on 20/10/2000 and displayed until 03/08/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 10/08/2000 and displayed until 20/10/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  paroxetine hydrochloride hemihydrate